Ad Scientiam
Djallel MEHDIOUI's work experience includes roles at various companies. Djallel worked as a Formateur/Délégué hospitalier gaz thérapeutique at PRECIPHAR pour Air Liquide santé Frannce since January 2018. Prior to that, they were a Responsable Médical Régional (MSL) Cardio-Thrombose / Respiratoire at Boehringer Ingelheim starting in February 2017. From October 2016, they worked as a Product Manager at Ad Scientiam. Before that, they were a Medical Representative at Pfizer from January 2013 until October 2015. Djallel also worked as a Visiteur Medical at INNOTHERA from March 2012 to December 2012. Djallel's first professional experience was as an Assurance Qualité Opérations at Boehringer Ingelheim from June 2010 to December 2010.
Djallel MEHDIOUI completed a Doctorate in Pharmacy from Université Mentouri de Constantine from 2002 to 2007. Later, from 2010 to 2011, they pursued a Master 2 degree in European Drug & Food Quality from Université Paris Cité. In 2015 to 2016, Djallel attended Ionis-STM, école de double compétence, where they obtained an MBA in Management & Biotechnologies.
Ad Scientiam
Ad Scientiam develop reliable solutions to measure disease evolution to accelerate treatment decisions to fight the disabilities.